卡介苗菌DNA抗肿瘤免疫的实验研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的:通过检测三组荷瘤裸鼠血清IFN-γ和TNF-α水平,NK、Mφ细胞杀伤活性,测定卡介苗菌DNA疫苗体内对肿瘤抑制率和对不同肿瘤细胞的体外抑制率,比较卡介苗菌制剂DNA与卡介苗的抗肿瘤免疫效果并探讨其免疫机制。
     方法:从卡介苗中纯化提取卡介苗菌DNA疫苗,采用细胞培养移植法,复制荷瘤裸鼠模型,将24只荷瘤裸鼠随机分为TES(2-三(羟甲基)甲基-3-氨基丙烷磺酸)组、卡介苗(BCG)组、DNA组,每组8只。于接种A549细胞株后第15天,TES组、BCG组、DNA组分别腹腔注射TES液、BCG液、DNA液各0.3 mL,隔2 d 1次,共8次。采用双抗体夹心酶联免疫检测法检测3组荷瘤裸鼠血清IFN-γ、TNF-α水平,及NK、Mφ细胞杀伤活性;卡介苗菌DNA疫苗体内对抑制率、对不同肿瘤细胞体外抑制率的测定。
     结果:卡介苗菌DNA制剂、BCG可抑制肿瘤生长。卡介苗菌制剂DNA可增强荷瘤裸鼠NK和Mφ杀伤活性,且其差异具有统计学意义P<0.05;及调节血清IFN-γ、TNF-α水平,且其差异具有统计学意义P<0.05。
     结论:卡介苗菌制剂DNA与卡介苗均有抗肿瘤免疫特性,而且卡介苗菌DNA制剂抗肿瘤免疫作用强于卡介苗。
Objective: To examine nude mice serum levels of IFN-γandTNF-αof.3 groups, to detect killing activity of NKand Mφcell and the suppression rate of tumor in vivo and different tumor cells in vitro , To compare Bacillus Calmette Guerin DNA with Bacillus Calmette Guerin on antitumor of effects and to explore the mechanism of immunity
     Methods: Bacillus Calmette-Cuerin DNA was extracted and purified from the BCG vaccine , the tumorbearing models of nude mice were established, 24 tumor bearing nude mice were randomly divided into TES,BCG and DNA groups and each group had 8 mice. 15 days after Vaccination A549,The mice in TES group,BCG group and DNA group were injected peritoneally with TES,BCG and DNA solution.Each tumor bearing nude mice was injected 0.3 mL,once every 2 days,a total of 8 times.The serum levels of IFN-γ, and TNF-α. were detected by enzyme linked immunosorbent assay,and killing activity of NK, Mφcell of three groups tumor bearing nude mice,the suppression rate of tumor in vivo and different tumor cells in vivo were detected.
     Results:BCG and DNA can suppress the tumor growth,NKMφcell killing activity were enhanced by DNA,and the difference were statistically significant , P <0.05;Bacillus Calmette-Cuerin DNA may adjust nude mice serum levels of IFN-γ,TNF-α., and the difference were statistically significantP<0.05.
     Conclusions: DNA and the BCG vaccine all have the characteristics of antitumor immune, but antitumor immunity effect of Bacillus Calmette-Cuerin DNA is stronger than of BCG..
引文
[1] Old LJ.Cancer vaccines:An overiew.[J].Cancer Immun, 2008,8(Suppl)1:1
    [2] Ikeda RK,Miller M,Nayer J,et al. Accumulation of peribronchial mast cells in a mouse model of ovalbumin allergen induced chronic airway inflammation: modulation by immunos- timulatory DNA sequences. [J].Immunol. 2003;171(9):4860-7.
    [3]李靖,刘伯华,夏玉坤,等.高致病性禽流感病毒血凝素基因定点突变及其原核表达[J].医学分子生物学杂志, 2006, 3(1): 8-12
    [4] Krieg AM, Hartmann G, Yi AK, et al. Mechanism of action of CpG DNA. Curr Top Microbiol [J].Immunol.2000, 247:1-21.
    [5] BarbaraB,LukasO,Dietrich K,et al.Mechanism of CpG motifs induce low levels TNF in human B lymphocytes possible adjuvants for Th1 response. [J]. Immunol.2001,2(21) :114-118.
    [6]聂建辉,王佑春。DNA疫苗的研究现状。[J].中国药事,2007,2(21):114-118
    [7] Ratliff TL,Gillen D,Catalona WJ.Requirement of a thymus dependent immuneresponsefor BCGmediated antitumour activity[J].Jurol. 1987, 137(1) :155-158.
    [8]史九华,膀胱癌的卡介苗免疫治疗[J].国外医学:预防.诊断.治疗用生物制品分册,2000,23(1):7-9.
    [9] SutmannH,JacobsenM,ReissK,etal.Mechanismsof bacillusCalncttc-Guerm mediated natura killer cell activation[J].1992,147(3):596-600.
    [10]Shizuo Shimada:In vivo augment of natural killer cell activity a deoxyribonucleic acid fraction of BCG[J].JCancerRes,1986,77 (3) :808-816.
    [11] Arthur M Krieg:CpG motifs in bacterial DNA trigger direct B cell activation[J]. Natural, 1995,374(3):546-549.
    [12] Ikeda RK,Miller M,Nayer J,et al. Accumulation of peribronchial mast cells in a mouse model of ovalbumin allergen induced chronic airway inflammation:modulation by immunos- timulatory DNA sequences [J]. Immunol.2003;171(9):4860-7.
    [13] Higgins D,Marshall J D,Traquina P,et al.Immunostimulatory DNA as a Vaccine Adjuvant[J]. Expert Rev Vaccines,2007,6(5):747-75.
    [14]李京培,毕克菊,王明丽.大肠埃希菌DNA对小鼠抗IFNα免疫应答的增强作用[J].安徽医科大学学报,2006,41(4):379-382.
    [15] Anold J. de Bover EC,Odonne MA,et al Immunotherapy of experimental bladder cancer with recombinant BCGexpressing interferongam[J].J Immunother2004,27 (2):116-123
    [16] Klinman.DM,Yi,AK.Beaucaqe.SL,ConoverJ,Kreiq AM.CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12,and interferon gamma[J].Proc Natl Acad Sci USA. 1996 Apr2; 93(7):2879-83.
    [17]历风元,蒋智敏,陈园等。金黄色葡萄球菌DNA对小鼠免疫功能的影响[J].江西医学院学报,2005,45(2):1-4.
    [18]赵越,江芳,张卓然。E.Coli DNA抗肿瘤免疫的实验研究[J].免疫学杂志,2000,1(4):278-282.
    [19]田志刚。[J].中国免疫学杂志,15(3):37-41.
    [20] JacoT,Walker PS,Krieg AM et al.Activation of cutaneous dendritic cells by CpG-containing oligodcoxyribonucleotids:a role for dendritic cells in the augmentation of Th1 responses by imm unostimulatory DNA.[J].Immun,1998,161: 3042-3049
    [21] Ae-KyungYi,JacqulineHc JohnSc,etalIFN-γpromotes IL-6 and IgM secretion in response to CpGmotifs in bacterialDNA and oligodeoxy nucleotides[J].Immunol,1996,156(5):558- 564.
    [22] Takeshita F ,GurselI,Ishii KJ,et al.Signal transduction pathways mediated by theinteraction of CpG DNA with Toll-like receptor 9 Semin[J].Immunol.2004, 16:17.
    [23] Sparwasser T, Miethke T, Lipford G, et al. Bacterial DNA causes septic shock.Nature. 1997,386(6623):336-337.
    [24] BauerS,KirschningCJ,HackerH,etal.Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA.2001,98(16): 9237- 9242.
    [25]耿叶慧,杨丽,毕殿洲。脂质体作为免疫佐剂的应用进展[J].中国药学杂志2007,42(9):649-651.
    [26] Raez LE,Fein,Podack ER.Lung cancer immunotherapy.Clin Med Res.2005 Nov;Proc Natl Acad Sci U S A.3(4):221-8.
    [27]刘刚,庞利群。卡介苗免疫治疗肿瘤的研究进展[J].江苏大学学报,2008,18(2):181-184.
    [28] LammDL,ThorDE,Harrissc,etal.Bacillus Calmette Guerin immunotherapy of superficial bladder cancer[J].Jurol,1980,124,38-40
    [1] Wolff JA, Malone RW, W illiams P, et al. Direct Gene Transfer into Mouse Muscle in vivo [J]. Science, 1990, 247: 1465-1468.
    [2]聂建辉,王佑春. DNA疫苗研究现状[J].中国药事.2007,21(2):114-118.
    [3] Jane McAllister and David Proll.Comparison of DNA Vaccine Delivery Systems: Intramuscular Injection Versus Gene Gun Administration [M ]·Australia; DSTO Platforms Sciences Laboratory, 2004.
    [4] Sbai H, Schneider J, Hill AV. Role of transfection in the priming of cyto-toxic T-cells by DNA-mediated immunization[J].Vaccine,2002,20(25-26):3137-3147.
    [5]石艳春. CpG DNA的识别、信号转导及对免疫细胞的效应[J].国外医学免疫学分册,2002,25(6):281-284.
    [6] Takeshita F ,Gursel I, Ishii KJ, et al. Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9[J] Semin Immunol.2004,16:17.
    [7] BurnsK, Clatworthy J, Martin L, et al .Tollip: a new component of the IL-1RI pathway, L inks IRAK to the IL-1 receptor[ J]. Nat Cell Bio, l 2000, 2(6): 346-351.
    [8]陈颖,项黎新,邵健忠. CpG DNA激活的受体信号转导及其反馈调控[J].细胞生物学杂志. 2006,28:556-560.
    [9] Baldwin As Jr. The NK-kB and IKB proteins: new discoveries and insigtes [J]. Annu Rev Immunol, 1996,14(11):649-683.
    [10] Hartman G, Krieg Am. Mechanism and function of a newly identifed CpG DNA motif human prim.ry B cells [J].Immunol,2000,164(2):944-953.
    [11]王瑾,张王刚. CpG ODN序列结构特征对免疫活性影响的研究进展[J].细胞与分子免疫学, 2008,24(12):1219-1221.
    [12] Krieg AM, Yi AK, Mason S, et al.CpG motifs in bacterial DNA trigger direct B-cell activation[J].Nature,1995,374(6522):546-549.
    [13]刘勇,吴超,陈军浩等. CpG对HBV感染者B细胞及Th1型细胞因子的活化作用[J].世界华人消化杂志,2008,16(14):1573-1576.
    [14] Chang HD,Radbruch A.The pro-and anti-inflammatory potential of interleukin-12[J].Ann N Y Acad Sci 2007;1109:40-46.
    [15] Girart MV,Fuertes MB,Domaica CI,Rossi LE,Zwirner NW.Engagement of TLR3,TLR7, andNKG2D regulate IFN-gamma secretion but notNKG2D-mediated cytotoxicity by human NKcells stimulated with suboptimal doses of IL-12[J].Immunol 2007;179:3472-3479
    [16] Iwabuchi N,Takahashi N, Xiao JZ, Miyaji K, Iwatsuki K. In vitro Th1 cytokine-independent Th2 suppressive effects of bifidobacteria[J].Microbiol Immunol 2007;51:649-660.
    [17]李宁,范学工,陈立章等. CpG-ODN活化人NK细胞的初步研究[J].中国免疫学杂志. 2005,21(6):424-426.
    [18] Takeshita S, Takeshita F, Haddad DE, et al. CpG oligodeoxynucleotides induce murine macrophages to up-regulate chemokine mRNA expression[J]. Cell Immunol,2000,206(2): 101-106.
    [19] maroula D,Julius MC,Robert L. Function of CD80 and CD86 on monocyte and stem cell derived dendritic cells [J]. Exp Mol Pathol,2003,75:217.
    [20]聂志林,靳风烁,梁培禾,叶锦. CpG-ODN促进小鼠骨髓来源的树突状细胞成熟作用的实验研究[J].重庆医学.2008,37(2):136-138.
    [21] Tan JK, ON' eillHC. Maturation requirements fordendritic cells in T cell stimulation leading to tolerance versus immunity[J]. JLeu-koc Bio,l 2005, 78(2): 319-324.
    [22] Xie J, Qian J, Wang S,etal. Novel and detrimental effects of lipopolysaccharide on in vitro generation of immature dendritic cells: Involvementofmitogen-activated protein kinase p38[J]. J Immuno,l 2003, 171(9): 4792-4800.
    [23] Pertmer, T. M. Eisenbraun MD, McCabe D et al .Gene gun-based nucleic acid immunization:elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA [J]. Vaccine, 1995, 13: 14270.
    [24] Allen, T. m., Vogel Tu , Fuller Dh , et a.l Induction of AIDS virus - specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesusmacaques vaccinated with aDNA prime/modified vaccinia virusAnkaraboost regimen [J]. J. Immuno,l 2000, 164: 4968.
    [25]郑惠,蔡方成,钟敏等.壳聚糖一DNA疫苗预防空肠弯曲菌感染的实验研究[J].中华预防医学杂志.2007,47(5):375-379.
    [26]史霖,刘珊一,程雁斌等.弓形虫多表位DNA疫苗的构建及其免疫保护作用[J].细胞与分子免疫学杂志. 2008,24(7):689-691.
    [27]王庆敏,胡振林,孙树汉,等.结核抗原ESAT-6基因的克隆及在大肠埃希菌中的表达[J].中华传染病杂志,2003,21(1):30-32.
    [28]饶桂荣,杨富强,莫国玉,陈光明.抗HBV的治疗性双质粒DNA疫苗的构建及初步药效学研究[J].中国免疫学杂志.2008,24(12):1121-1124.
    [29]杨亮,孙晚晴,王莉等.一种C型CpG ODN对柯萨奇病毒感染小鼠的作用初探[J].细胞与分子免疫学杂志.2009,25(2):115-117.
    [30]黄红平,杨东亮. SARS病毒S2蛋白的原核表达与DNA疫苗的构建[J].华中科技大学学报(医学版).2008,37(2):196-199.
    [31]杜英,黄玉敏,孙蕾. CpG ODN对人胃癌BGC 823细胞RNA转染的脐血树突状细胞诱导CTL活性影响的研究[J].中国现代医学杂志.2007,17(11):1312-1315.
    [32] Speiser DE,Lienard D,RuferN,et al.Rapid and strong humanCD8十T cell responses to vaccination with peptide,IFA,and CpG oligedeoxymueleotide 7909[J].J Clin Invest,2005,115(3):739-746.
    [33]杨晓峰,王鹏,张晓俊. Ag85A及Ag85B-DNA疫苗对移植性小鼠膀胱肿瘤免疫治疗的实验研究[J].临床泌尿外科杂志.2008,23(9):704-707.
    [34]历风元,蒋智敏,周文清等.金黄色葡萄球菌DNA抗肿瘤免疫的试验研究[J]. .江西医学院学报2008,48(6):28-31.
    [35] Mason KA, Neal R, Hunter N, et al. CpG oligodeoxynucleotides are potent enhancers of radio and chemoresponses of murine tumors [J].Radiother Oncol,2006,80(2):192-198.
    [36] ZHU J,YAMANE1 H,COTE-SIERRA1 J,et al.GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production,selective growth of Th2 cells and inhibition of Th1 cell-specific factors[J].Cell Research,2006,16(1):3-10.
    [37] NAKAMURA Y,GHAFFAR O,OLIVENSTEIN R,et al.Gene expression of GATA-3 transcription factor is increased in atopic asthma[J].J Allergy Clin Immunol,1999,103(2): 215-222.
    [38]夏春伟,吕丽丽,刘萍莉等. CpG ODN对哮喘小鼠气道炎症及GATA-3的影响[J].中国现代医学杂志.2008,18(5):563-566.
    [39]吴奎,孙鲲,毕玉田等.屋尘螨过敏原DNA疫苗对哮喘模型小鼠Foxp3调节性T细胞功能的影响[J].第三军医大学学报.2008,30(5):374-377.
    [40]李长优,高美华,杨玲玲等.局部应用CpG ODN治疗变态反应性结膜炎的实验研究[J].眼科心进展.2008,28(3):172-176.
    [41]李文波。CpG DNA的免疫学活性在疾病防治中的作用[J]。细胞与分子免疫学杂志。2000,16(4)363-365。